Cisplatin-lnduced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity (Q67485466)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1309303%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1309303%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

Cisplatin-lnduced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity (English)

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

1 reference

1 reference

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

author name string

G. Cavaletti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309303

11 September 2022

L. Marzorati

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309303

11 September 2022

G. Bogliun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309303

11 September 2022

N. Colombo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309303

11 September 2022

M. Marzola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309303

11 September 2022

M. R. Pittelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309303

11 September 2022

G. Tredici

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309303

11 September 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1309303%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 September 2019

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819920101%2969%3A1%3C203%3A%3AAID-CNCR2820690133%3E3.0.CO%3B2-1

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309303

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1309303%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1309303%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1309303%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

203-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1309303%20AND%20SRC:MED&resulttype=core&format=json

Fundamental studies with cisplatin

14 September 2019

cites work

1

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

30 November 2023

2

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

Cisplatin neurotoxicity

3

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

30 November 2023

4

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

30 November 2023

5

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

30 November 2023

6

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry

30 November 2023

9

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Hypothyroidism and polyneuropathy

30 November 2023

10

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

Cancer Treatment Reports

11

62

819

Kedar

1978

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Peripheral sensory neuropathy and cisplatin chemotherapy

30 November 2023

12

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

30 November 2023

13

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Electrophysiological study of the peripheral and central neurotoxic effect of cis-platin.

30 November 2023

14

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

15

12

2336

Petit

1983

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Prospective nerve conduction studies in cisplatin therapy

30 November 2023

16

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Prospective study of nerve conduction parameters and serum magnesium following cisplatin therapy

30 November 2023

18

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment

30 November 2023

20

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Neurotoxic effects of cisplatin therapy

30 November 2023

22

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement

30 November 2023

23

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and by morphometry

30 November 2023

24

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Cisplatin neuropathy with Lhermitte's sign

30 November 2023

26

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

Cancer Treatment Reports

27

70

905

Eeles

1986

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

The development of Lhermitte's sign during cisplatin chemotherapy. Possible drug-induced toxicity causing spinal cord demyelination

30 November 2023

28

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity

30 November 2023

29

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

Tissue platinum concentrations and cisplatin schedules

30 November 2023

30

1 reference

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19920101)69:1%3C203::AID-CNCR2820690133%3E3.0.CO;2-1

30 November 2023

Identifiers

10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1309303%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference